Modulation of ~-mediated antinociception by ~ agonists: characterization with antagonists
暂无分享,去创建一个
H. Mosberg | R. Rothman | F. Porreca | Q. Jiang | J. Heyman
[1] H. Mosberg,et al. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin. , 1989, European journal of pharmacology.
[2] J. Holaday,et al. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. , 1988, The Journal of pharmacology and experimental therapeutics.
[3] T. Burks,et al. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine. , 1988, The Journal of pharmacology and experimental therapeutics.
[4] H. Mosberg,et al. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [d-Pen2, d-Pen5] enkephalin in the mouse F. Porreca, J.S. Heyman, H.I. Mosberg, J.R. Omnaas and J.L. Vaught, J. Pharmacol. Exp. Ther., 241 (1987) 393–400 , 1987, Pain.
[5] M. Herkenham,et al. Autoradiographic evidence for two classes of mu opioid binding sites in rat brain using [125I]FK33824 , 1987, Peptides.
[6] J. Holaday,et al. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography. , 1987, European journal of pharmacology.
[7] P. Portoghese,et al. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice. , 1987, The Journal of pharmacology and experimental therapeutics.
[8] H. Mosberg,et al. Opioid δ-receptor involvement in supraspinal and spinal antinociception in mice , 1987, Brain Research.
[9] R. Raffa,et al. C57BL/6J-bgJ (beige) mice: differential sensitivity in the tail flick test to centrally administered mu- and delta-opioid receptor agonists. , 1987, Life sciences.
[10] R. Tallarida,et al. Estimation of the affinity of naloxone at supraspinal and spinal opioid receptors in vivo: studies with receptor selective agonists. , 1986, Life sciences.
[11] G. Pasternak,et al. Naloxonazine actions in vivo. , 1986, European journal of pharmacology.
[12] G. Pasternak,et al. [D-Pen2,D-Pen5]enkephalin (DPDPE): a δ-selective enkephalin with low affinity for μ1 opiate binding sites , 1986 .
[13] E. J. Simon,et al. Purification of an active opioid-binding protein from bovine striatum. , 1985, The Journal of biological chemistry.
[14] T. Burke,et al. Leucine enkephalin noncompetitively inhibits the binding of [3H]naloxone to the opiate mu-recognition site: Evidence for delta←mu binding site interactions in vitro , 1985, Neuropeptides.
[15] M. Herkenham,et al. Evidence that the delta-selective alkylating agent, FIT, alters the mu-noncompetitive opiate delta binding site , 1985, Neuropeptides.
[16] M. Herkenham,et al. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site. , 1985, Molecular pharmacology.
[17] C. Pert,et al. Effect of β‐FNA on Opiate δ Receptor Binding , 1984 .
[18] V. Hruby,et al. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. , 1984, The Journal of pharmacology and experimental therapeutics.
[19] C. Pert,et al. Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitro , 1984, Neuropeptides.
[20] A. Goldstein,et al. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. , 1984, Molecular pharmacology.
[21] M. Giles,et al. ICI 174864: A highly selective antagonist for the opioid Δ-receptor , 1984 .
[22] A. Takemori,et al. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. , 1983, The Journal of pharmacology and experimental therapeutics.
[23] J. Holaday,et al. Multiple opioid receptors: Evidence for μ -δ binding site interactions in endotoxic shock , 1983 .
[24] J. Morley,et al. Selective antagonists at the opiate delta-receptor. , 1982, Life sciences.
[25] R. Barrett,et al. The effects of receptor selective opioid peptides on morphine-induced analgesia. , 1982, European journal of pharmacology.
[26] R. Rothman,et al. Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain. , 1982, Molecular pharmacology.
[27] R. Rothman,et al. Allosteric coupling between morphine and enkephalin receptors in vitro. , 1982, Molecular pharmacology.
[28] G. Pasternak,et al. Irreversible opiate agonists and antagonists: the 14- hydroxydihydromorphinone azines , 1982, Journal of Neuroscience.
[29] R. Rothman,et al. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia. , 1982, Life sciences.
[30] P. Portoghese,et al. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. , 1982, The Journal of pharmacology and experimental therapeutics.
[31] B. Morgan,et al. Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors , 1981 .
[32] R. Tallarida,et al. Manual of Pharmacologic Calculations , 1981 .
[33] H. Loh,et al. Opiate and peptide interaction: effect of enkephalins on morphine analgesia. , 1980, European journal of pharmacology.
[34] P. Cuatrecasas,et al. Multiple opiate receptors , 1980, Trends in Neurosciences.
[35] G. Pasternak,et al. Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors , 1980 .
[36] D. L. Larson,et al. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.
[37] P. Cuatrecasas,et al. Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. , 1979, The Journal of biological chemistry.
[38] A. Takemori,et al. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. , 1979, The Journal of pharmacology and experimental therapeutics.
[39] John Hughes,et al. Endogenous opioid peptides: multiple agonists and receptors , 1977, Nature.
[40] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[41] Janssen Pa,et al. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats. , 1963 .
[42] T. Haley,et al. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.